Human Immunology Biosciences (HI-Bio) is leading clinical immunology into its next chapter with therapies that target cellular drivers of disease. HI-Bio uses a precision medicine approach to deliver therapies for patients with the auto-immune, allergic and inflammatory diseases that can together be referred to as immune-mediated diseases (IMDs).
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $215M
Founded date: 2021
Investors 2
Date | Name | Website |
16.04.2022 | Jeito Capi... | jeito.life |
- | Alpha Wave... | alphawaveg... |
Funding Rounds 2
Date | Series | Amount | Investors |
05.01.2024 | Series B | $95M | - |
01.11.2022 | Series A | $120M | - |
Mentions in press and media 7
Date | Title | Description | Source |
05.01.2024 | Fierce Biotech Fundraising Tracker '24: Lykos lands $100M; H... | A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being fu... | fiercebiot... |
04.01.2024 | HI-Bio Completes $95M Series B Round | SOUTH SAN FRANCISCO, CA, HI-Bio today announced the closing of a $95 million Series B financing ro... | vcnewsdail... |
04.01.2024 | HI-Bio Raises $95M in Series B Funding | Human Immunology Biosciences (HI-Bio), a San Francisco, CA-based clinical-stage biotechnology compan... | finsmes.co... |
01.11.2022 | Arch-backed HI-Bio launches with 2 clinical-stage therapies ... | Oftentimes, a newly launched biotech’s first task is to pour initial financing into the preclinical ... | fiercebiot... |
01.11.2022 | Human Immunology Biosciences Raises $120M in Funding | Human Immunology Biosciences (HI-Bio™), a South San Francisco, CA-based clinical-stage biotechnology... | finsmes.co... |
01.11.2022 | HI-Bio Launches With $120M | SOUTH SAN FRANCISCO, CA, Human Immunology Biosciences announced its launch with $120 million in fi... | vcnewsdail... |
- | Human Immunology Biosciences | “HI-Bio leverages human genetic and immunological insights to deliver targeted, effective medicines ... | fastfounde... |